Vantis Vascular successfully closed a #SeriesB-1 preferred financing round worth $10 million. 💬 CEO Jason Turner shared: “This funding is a critical milestone for Vantis and will allow us to continue our ongoing product development efforts, expand our team and initiate US commercialization of the CrossFast advanced delivery system for complex high-risk PCI procedures.” 👉 Read more: https://lnkd.in/dkdPXrgZ #MedicalDevice #MedTech #MedicalEquipment #HealthTech #SeriesA #MedicalDevices #Medicine #TechNews #Funding #MedTechFunding #FundingRound #AngelInvestment #GSCapitalConnect
